Position in TNGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$116,999,645
+$61,022,391 QoQ
Shares Held
3,742,791
+39.9% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 247 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. TNGX ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in TNGX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $116,999,645 | 3,742,791 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $55,977,254 | 2,675,777 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,625,391 | 2,553,656 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $15,815,326 | 1,882,777 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $9,056,834 | 1,768,913 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,895,308 | 1,383,437 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,284,127 | 1,386,449 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $10,535,617 | 1,368,262 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $10,515,235 | 1,225,552 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $9,000,267 | 1,133,535 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,861,309 | 1,097,102 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $11,654,032 | 1,034,994 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,116,938 | 938,837 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,503,140 | 886,871 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,179,668 | 852,368 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,039,942 | 839,763 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,486,965 | 990,500 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,497,532 | 593,342 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $6,423,716 | 587,177 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,542,250 | 428,635 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 BCTG | — | 14,009 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||